It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Species within the Enterobacter cloacae complex (ECC) include globally important nosocomial pathogens. A three-year study of ECC in Germany identified Enterobacter xiangfangensis as the most common species (65.5%) detected, a result replicated by examining a global pool of 3246 isolates. Antibiotic resistance profiling revealed widespread resistance and heteroresistance to the antibiotic colistin and detected the mobile colistin resistance (mcr)−9 gene in 19.2% of all isolates. We show that resistance and heteroresistance properties depend on the chromosomal arnBCADTEF gene cassette whose products catalyze transfer of L-Ara4N to lipid A. Using comparative genomics, mutational analysis, and quantitative lipid A profiling we demonstrate that intrinsic lipid A modification levels are genospecies-dependent and governed by allelic variations in phoPQ and mgrB, that encode a two-component sensor-activator system and specific inhibitor peptide. By generating phoPQ chimeras and combining them with mgrB alleles, we show that interactions at the pH-sensing interface of the sensory histidine kinase phoQ dictate arnBCADTEF expression levels. To minimize therapeutic failures, we developed an assay that accurately detects colistin resistance levels for any ECC isolate.
Taxonomical complexity has muddled the classification of clinically relevant Enterobacter species. Authors carry out a genome-based study on clinical isolates to investigate colistin resistance and heteroresistance in Enterobacter.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 German Center for Infection Research (DZIF), Braunschweig, Germany (GRID:grid.452463.2); Justus Liebig University, Institute of Medical Microbiology, Gießen, Germany (GRID:grid.8664.c) (ISNI:0000 0001 2165 8627)
2 Priority Area Infections, Research Center Borstel, Leibniz Lung Center, Division of Bioanalytical Chemistry, Borstel, Germany (GRID:grid.418187.3) (ISNI:0000 0004 0493 9170)
3 NMIMS (Deemed-to-be) University, Department of Biological Sciences, Sunandan Divatia School of Science, Mumbai, India (GRID:grid.444588.1) (ISNI:0000 0004 0635 4408)
4 German Center for Infection Research (DZIF), Braunschweig, Germany (GRID:grid.452463.2); Justus Liebig University, Institute of Medical Microbiology, Gießen, Germany (GRID:grid.8664.c) (ISNI:0000 0001 2165 8627); Justus Liebig University, Institute of Hygiene and Environmental Medicine, Gießen, Germany (GRID:grid.8664.c) (ISNI:0000 0001 2165 8627)
5 German Center for Infection Research (DZIF), Braunschweig, Germany (GRID:grid.452463.2); University of Lübeck, Department of Infectious Diseases and Microbiology, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672)
6 German Center for Infection Research (DZIF), Braunschweig, Germany (GRID:grid.452463.2); Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität of Berlin and Berlin Institute of Health, Institute of Hygiene and Environmental Medicine, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662)
7 German Center for Infection Research (DZIF), Braunschweig, Germany (GRID:grid.452463.2); Tübingen University, Institute of Medical Microbiology and Hygiene, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447); Tübingen University, Division of Infectious Diseases, Department of Internal Medicine I, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447); Paracelsus Medical University, Klinikum Nürnberg, Institute of Clinical Hygiene, Medical Microbiology and Infectiology, Nürnberg, Germany (GRID:grid.419835.2) (ISNI:0000 0001 0729 8880)
8 German Center for Infection Research (DZIF), Braunschweig, Germany (GRID:grid.452463.2); Tübingen University, Division of Infectious Diseases, Department of Internal Medicine I, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
9 German Center for Infection Research (DZIF), Braunschweig, Germany (GRID:grid.452463.2); Albert-Ludwigs-University, Institute for Medical Microbiology and Hygiene, Freiburg, Germany (GRID:grid.5963.9)
10 German Center for Infection Research (DZIF), Braunschweig, Germany (GRID:grid.452463.2); Faculty of Medicine and University Hospital and Medical Center, Albert-Ludwigs-University, Division of Infectious Diseases, Department of Medicine II, Freiburg, Germany (GRID:grid.5963.9)
11 University of Lübeck, Department of Infectious Diseases and Microbiology, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672); Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität of Berlin and Berlin Institute of Health, Institute of Hygiene and Environmental Medicine, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662)
12 German Center for Infection Research (DZIF), Braunschweig, Germany (GRID:grid.452463.2); Tübingen University, Institute of Medical Microbiology and Hygiene, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
13 German Center for Infection Research (DZIF), Braunschweig, Germany (GRID:grid.452463.2); Faculty of Medicine and University Hospital Cologne, University of Cologne, Institute for Medical Microbiology, Immunology, and Hygiene, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777)
14 German Center for Infection Research (DZIF), Braunschweig, Germany (GRID:grid.452463.2); Faculty of Medicine and University Hospital Cologne, University of Cologne, Department I of Internal Medicine, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777); University Hospital Frankfurt, Goethe University Frankfurt, Department of Internal Medicine, Infectious Diseases, Frankfurt, Germany (GRID:grid.6190.e)
15 German Center for Infection Research (DZIF), Braunschweig, Germany (GRID:grid.452463.2); Priority Area Infections, Research Center Borstel, Leibniz Lung Center, Division of Bioanalytical Chemistry, Borstel, Germany (GRID:grid.418187.3) (ISNI:0000 0004 0493 9170); Member of the German Center for Lung Research (DZL), Site: Research Center Borstel, Airway Research Center North, Borstel, Germany (GRID:grid.418187.3) (ISNI:0000 0004 0493 9170)
16 Berlin, Germany (GRID:grid.418187.3)
17 Freiburg, Germany (GRID:grid.418187.3)
18 Köln, Germany (GRID:grid.418187.3)
19 Lübeck, Germany (GRID:grid.418187.3)
20 Tübingen, Germany (GRID:grid.418187.3)